506938 — Kappac Pharma Balance Sheet
0.000.00%
HealthcareMicro Cap
Annual balance sheet for Kappac Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2017 March 31st | C2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PRESS | Interim Report | PRESS | PRESS | PRESS |
| Standards: | — | — | — | — | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 220 | 0.13 | 0.13 | 0.019 | 0.017 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.001 | 1.92 | 46.9 | 196 | 201 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 220 | 2.2 | 47.2 | 196 | 201 |
| Net Property, Plant And Equipment | 0 | 0 | 0 | 0 | 0 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 380 | 382 | 434 | 364 | 342 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.491 | 2.53 | 54.9 | 0.574 | 0.704 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.491 | 2.53 | 54.9 | 0.574 | 0.704 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 380 | 380 | 379 | 363 | 341 |
| Total Liabilities & Shareholders' Equity | 380 | 382 | 434 | 364 | 342 |
| Total Common Shares Outstanding |